Ginkgo Bioworks Inc.

DNA | NYSE

Price Alert Chart Builder DCF Calculator

$7.98

+$0.10 (+1.27%)

At close: Sep 21, 2026, 4:00 PM ET

$7.91

-$0.07 (-0.88%)

Pre-market: Sep 22, 2026, 4:33 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	170.16M	227.04M	251.46M	477.71M	313.84M	76.66M
Cost of Revenue	31.52M	38.55M	54.01M	204.22M	129.69M	15.61M
Gross Profit	138.63M	188.49M	197.45M	273.49M	184.15M	61.05M
Operating Income	-315.28M	-559.76M	-864.41M	-2.21B	-1.83B	-137.03M
Interest Income	22.62M	38.61M	57.22M	20.26M	837K	2.58M
Pretax Income	-313.6M	-547.51M	-892.94M	-2.12B	-1.84B	-124.83M
Net Income	-312.76M	-547.03M	-892.87M	-2.1B	-1.83B	-126.61M
Selling & General & Admin	183.29M	246.16M	385.03M	1.43B	862.95M	38.31M
Research & Development	243.77M	424.06M	580.62M	1.05B	1.15B	159.77M
Other Expenses	26.85M	78.03M	96.21M	n/a	n/a	n/a
Operating Expenses	453.91M	748.25M	1.06B	2.48B	2.01B	198.07M
Interest Expense	n/a	94K	93K	106K	2.37M	2.39M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	485.43M	786.8M	1.12B	2.69B	2.14B	213.68M
Income Tax Expense	-837K	-479K	-71K	-15.03M	-1.48M	1.89M
Shares Outstanding (Basic)	55.46M	51.89M	48.53M	41.93M	32.95M	31.65M
Shares Outstanding (Diluted)	55.46M	51.89M	48.61M	42M	34.01M	31.87M
EPS (Basic)	-5.64	-10.54	-18.37	-50.15	-53.83	-3.97
EPS (Diluted)	-5.64	-10.54	-18.40	-50.20	-55.53	-4
EBITDA	-254.61M	-484.39M	-821.29M	-2.06B	-1.81B	-108.59M
EBIT	-313.6M	-547.41M	-892.85M	-2.12B	-1.84B	-122.45M
Depreciation & Amortization	58.99M	63.02M	71.55M	61.63M	29.08M	13.86M